Evidence map›Paper›PMID 31427961›Full record

ArticleFrontiers in pharmacology2019

Antibacterial Silver Nanomaterial Synthesis From

Mohammad Oves, Mohd Ahmar Rauf, Afzal Hussain, Huda A Qari, Aftab Aslam Parwaz Khan, Pir Muhammad, Md Tabish Rehman, Mohammad Fahad Alajmi, Iqbal I M Ismail

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Saturated Iso-Type Fatty Acids from the Marine BacteriumPharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Zinc Oxide Nanoparticles Biosynthesized byPlants (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Plants (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Green synthesis of silver nanoparticles bySaudi journal of biological sciences · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Metal-Based Nanoparticles as Antimicrobial Agents: An Overview.Nanomaterials (Basel, Switzerland) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mohammad OvesCenter of Excellence in Environmental Studies, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohd Ahmar RaufInternational Joint Centre for Biomedical Innovation, Henan University, Kaifeng, China.
Afzal HussainDepartment of Phamocognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Huda A QariCenter of Excellence in Environmental Studies, King Abdulaziz University, Jeddah, Saudi Arabia.
Aftab Aslam Parwaz KhanDepartment of Chemistry, King Abdulaziz, University, Jeddah, Saudi Arabia.
Pir MuhammadInternational Joint Centre for Biomedical Innovation, Henan University, Kaifeng, China.
Md Tabish RehmanDepartment of Phamocognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Mohammad Fahad AlajmiDepartment of Phamocognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Iqbal I M IsmailCenter of Excellence in Environmental Studies, King Abdulaziz University, Jeddah, Saudi Arabia.
King Abdulaziz University · SAKing Saud University · SAHenan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the significance of biological and eco-friendly nanomaterials, in the present study, we have synthesized silver nanoparticles from the exopolysaccharide of recently recovered bacterial strain CEES51 from the Red Sea coastal area of Jeddah, Saudi Arabia. 16S ribosomal RNA gene sequencing was used to characterize the isolated bacteria, and it was identified as

Indexed as

antibacterialbiofilmexopolysaccharidelipid peroxidationMesoflavibacter zeaxanthinifaciensis

Identifiers

PMID31427961
PMCPMC6688106
OpenAlexW2966202210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.